Scientific Basis of EPA Actions, and More from CRS
Noteworthy new products from the Congressional Research Service that Congress has withheld from online public distribution include the following.
U.S. Trade Concepts, Performance, and Policy: Frequently Asked Questions, November 17, 2014
Supreme Court Hears Oral Argument in Federal Whistleblower Case, CRS Legal Sidebar, November 14, 2014
Scientific Basis of Environmental Protection Agency (EPA) Actions: H.R. 1422 and H.R. 4012, CRS Insights, November 17, 2014
International Climate Change Financing: The Green Climate Fund (GCF), November 17, 2014
The Battle over Cable Boxes, CRS Insights, November 14, 2014
The Regional Greenhouse Gas Initiative: Lessons Learned and Issues for Policy Makers, November 14, 2014
Keystone XL Pipeline: Overview and Recent Developments, November 13, 2014
Federal Proposals to Tax Marijuana: An Economic Analysis, November 13, 2014
Childhood Overweight and Obesity: Data Brief, November 13, 2014
Veterans and Homelessness, November 13, 2014
When Will DOD Modernize its Electronic Health Records Systems?, CRS Insights, November 13, 2014:
President Obama’s November 2014 Visit to China: The Bilateral Agreements, CRS Insights, November 13, 2014
Defense: FY2015 Authorization and Appropriations, November 13, 2014
Using the NIST as an example, the Radiation Physics Building (still without the funding to complete its renovation) is crucial to national security and the medical community. If it were to go down (or away), every medical device in the United States that uses radiation would be decertified within 6 months, creating a significant single point of failure that cannot be quickly mitigated.
The federal government can support more proactive, efficient, and cost-effective resiliency planning by certifying predictive models to validate and publicly indicate their quality.
We need a new agency that specializes in uncovering funding opportunities that were overlooked elsewhere. Judging from the history of scientific breakthroughs, the benefits could be quite substantial.
The cost of inaction is not merely economic; it is measured in preventable illness, deaths and diminished livelihoods.